(2R,3R,4R,5R)-2-(4-Amino-5-fluoropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol

A ribonucleoside analogue.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

(2R,3R,4R,5R)-2-(4-Amino-5-fluoropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol is a 7-deaza-7-fluoropurine derivative. It inhibits SARS-CoV-2 in vitro (Zandi et al., 2020).

(2R,3R,4R,5R)-2-(4-Amino-5-fluoropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol on PubChem


Synonyms

7-deaza-7-fluoropurine derivative 2

 

Structure image - (2R,3R,4R,5R)-2-(4-Amino-5-fluoropyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol

C[C@]1([C@@H]([C@H](O[C@H]1N2C=C(C3=C(N=CN=C32)N)F)CO)O)O


Supporting references

Link Tested on Impact factor Notes Publication date
Repurposing Nucleoside Analogs for Human Coronaviruses
Small molecule In vitro
PBM and CEM cells (cytotoxicity only), Huh-7 cells; Vero CCL-81 cells; RD cells; Caco-2 cells; Calu3 cells; SARS-CoV-2 (NR-52281: USA-WA/2020) 4.68

Inhibits SARS-CoV-2 in a single-digit-micromolar range with no cytotoxicyty detected up to 100 μM in Vero cells.

Oct/29/2020